E-Briefings

Yale researchers find that an AstraZeneca cancer pill improves survival rates when taken after lung cancer surgery.

Georgia Tech researchers applied a different approach to their machine learning algorithm to predict what medications would best treat different ovarian cancers.

An immune system digital twin supporting precision medicine is still rather far from prime time; however, existing research may be sufficient to begin developing an initial prototype.

Healthcare leaders will want to follow the nascent field of sound wave therapy as more research and the findings of clinical trials emerge.

Precision Medicine Institute’s noted of liquid biopsy research, collaborations, and advancements as 2022 approaches year-end.

From discovery of a new type of asthma driver to assessing personalized risk with using inhaled corticosteroids, metabolomics research brings new information about severe asthma.

To streamline workflow and reduce cost of testing, researchers at Brown University and Columbia University explore new single-cell analysis (SCA) technology and techniques in fresh and frozen tissues.

One study illuminates the genes that may prove useful in predicting how ulcerative colitis will progress in children and teens; the other investigates poorly understood disease-relevant biological pathways.

Projects at Community Health Systems and other health networks likely will produce evidence that will enhance precision medicine programs.

Rapidly identifying rare genetic conditions has been difficult using traditional testing, according to experts implementing rWGS at a national scale.